UE LifeSciences

United States
South Weldon, North Carolina, United States, 19104

Company profile

UE LifeSciences company profile

Growth-stage FemTech company in preventive oncology space with proven B2B product suite & promising pipeline. Hallmark product regulatory cleared, validated through independent trials & commercially scaling in multiple markets with high-margin, pay-per-use revenue model. Big Pharma collaboration opening national-scale markets. Strong product pipeline in breast and cervical cancer space.

Business identity

Contact email
[email protected]
Phone number
+12674773252
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2009-01-01, Month

Headquarters

Postal code
19104
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
8
Total equity funding
$4.7M
Last funding
Seed / $480,308 / 2021-11-23
Last equity funding
Seed / $480,308
Investors
7
Lead investors
5
Founders
3
Articles
27

Founders and investors

Founders

Bhaumik SanghviMatt CampisiMihir Shah

Lead investors

Aarin CapitalBayer G4AKiran Mazumdar-ShawPennsylvania Department of Community & Economic DevelopmentThe Pfizer Foundation

Investors

Aarin CapitalLyfeBulbPennsylvania Department of Community & Economic DevelopmentThe Pfizer FoundationUnitus Ventures